Home › Trial NCT00139243
Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck
- Trial IDNCT00139243
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorDana-Farber Cancer Institute
- Enrollment30
- Start date1997-10
- ConditionsSquamous Cell Carcinoma · Carcinoma of Head and/or Neck
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.